GA
TXG icon

Greenspring Associates’s 10x Genomics TXG Stock Holding History

Greenspring Associates’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,821
Closed -$511K – 16
2021
Q1 		$511K Buy
+2,821
New +$487K 0.41% 6
2020
Q4 		– Sell
-3,268
Closed -$407K – 15
2020
Q3 		$407K Buy
+3,268
New +$343K 0.63% 11
2020
Q2 		– Sell
-3,427
Closed -$214K – 12
2020
Q1 		$214K Buy
+3,427
New +$267K 0.09% 11

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
MCAV
Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Greenspring Associates's TXG Position: Q2 2021 in Review

Greenspring Associates sold out of 10x Genomics (TXG) in Q2 2021, closing a stake of 2,821 shares — an estimated $511K sold.

Greenspring Associates first reported a position in TXG in Q1 2020 and held it in 3 quarters. The position peaked at $511K in Q1 2021. 340 funds tracked by Wall St. Rank hold TXG as of Q2 2021.

  • Greenspring Associates reported no remaining 10x Genomics position as of Q2 2021 after selling out during the quarter.
  • Greenspring Associates sold 2,821 10x Genomics shares in Q2 2021, an estimated $511K.
  • Greenspring Associates first reported a position in 10x Genomics in Q1 2020 and held it in 3 quarters.
  • Greenspring Associates's 10x Genomics position peaked at $511K in Q1 2021.
  • 340 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2021.

Based on Greenspring Associates's 13F filing for Q2 2021, filed 13 Aug 2021.